AUGUST 20, 2025 — 350 MARYLAND EMPLOYEES
The company is laying off 350 employees in its gene therapy manufacturing division in Baltimore, Maryland.
According to a spokesperson, “Due to an unexpected shift in demand from a large customer, we have made the necessary decision to reduce our workforce in Baltimore. It is never easy to see talented colleagues leave Catalent, and we remain committed to providing them with transition support as they manage this change. Our gene therapy business continues to see strong growth and we look forward to working on behalf of customers to deliver novel therapies for patients with genetic diseases/disorders.”
It is rumored that the customer is Sarepta Therapeutics which is also undergoing layoffs.
MARCH 28, 2024 — 130 INDIANA EMPLOYEES
The company will lay off approximately 130 staffers at its manufacturing and filling facility located in Bloomington, Indiana. This is unrelated to the 300 positions the company previously eliminated as part of its cost-cutting campaign.
According to a company statement, “As part of Catalent’s commitment to driving long-term sustainable growth, the company has been focusing on increasing efficiencies and reducing costs across our business.”
FEBRUARY 19, 2024 — 300 EMPLOYEES GONE
The company confirms it has reduced its headcount by about 300 employees between October and December 2023 as part of its ongoing restructuring plans as it moves closer to its $16.5 billion sale to Novo Holdings by the end of 2024.
JUNE 15, 2023 — Original post…
Somerset, New Jersey-based Catalent, a pharmaceutical manufacturer and provider of drug delivery technologies, has announced a restructuring initiative resulting in a reduction in force.
The reduction in force will impact 150 employees located in Bloomington, Indiana.
Catalent General Manager Anibal Carlo noted that "the company’s growth during the pandemic is not sustainable, and the layoffs are the result of restructuring."
Catalent Pharma Solutions laid off approximately 400 employees at its Bloomington, Indiana location in November 2023.
At the time, a spokesperson noted, “During the pandemic, Catalent significantly increased its cost base to continue to meet the needs of our customers and deliver essential products, as well as to meet the needs specific to the pandemic. Given the current phase of the pandemic, the challenging global economic environment, and the need to ensure that Catalent continues to operate efficiently, we have made the difficult decision to reduce or delay some capital expenditure projects and also reduce the size of our workforce in certain areas."
“We appreciate every Catalent worker’s contributions and are offering severance and job transition support to all impacted employees.”
"Bloomington facility played a critical role in producing vaccines and therapies for public health response during the pandemic. But as the pandemic has receded, global demand for vaccines has declined."
Change is coming. There will always be a tomorrow, no matter how much you may try to ignore it. There are no guarantees in life or promises for a bright future. We see good people being laid off through no fault of their own. Just because something bad hasn't happened yet, doesn't mean it won't. It can happen to anyone, anytime, anywhere. No one is guaranteed to wake up tomorrow and still have a job by evening. Are you now wondering, Am I Next?
